An article under the headline ‘Steps needed to set up SMA genetic lab in Bangladesh’ written by Md Manzurul Alam was published in the editorial page (p-4) in the Bangladesh Today on March 23, 2013.
Mistakenly, the writer wrote ‘Roche Bangladesh Ltd is trying to get approval for selling oral medicine ‘Risdiplam’ in Bangladesh’. It should be read Roche Bangladesh has already gotten approval and registration for Risdiplam from the Directorate General of Drug Administration (DGDA). It also received FDA approval in 2020. They have been approached by the patients’ families and physicians so that they can get access to Risdiplam free of cost till 2024.
Md Manzurul Alam
manzurul_1977@yahoo.com
